Marshall Wace’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-96,111
Closed -$207K 2268
2024
Q2
$207K Buy
96,111
+13,613
+17% +$29.3K ﹤0.01% 2084
2024
Q1
$268K Sell
82,498
-254,823
-76% -$828K ﹤0.01% 1888
2023
Q4
$6.91M Sell
337,321
-379,460
-53% -$7.78M 0.01% 665
2023
Q3
$11.5M Buy
+716,781
New +$11.5M 0.02% 557